Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 13 record(s)

Req # A-2020-18432

Copies of the daily calendar meetings, calls and other taskings for Mitchell Levine from June 1, 2019 to November 18, 2020.

Organization: Patented Medicine Prices Review Board Canada

84 page(s)
December 2020

Req # A-2020-18433

Copies of the daily calendar meetings, calls and other taskings for Melanie Bourassa-Forcier from June 1, 2019 to November 18, 2020.

Organization: Patented Medicine Prices Review Board Canada

18 page(s)
December 2020

Req # A-2020-18434

Copies of all completed Access to Information requests: A-2018-001, A-2018-002, A-2018-003, A-2018-004 and A-2019-0003.

Organization: Patented Medicine Prices Review Board Canada

1978 page(s)
December 2020

Req # A-2020-18435

All briefing notes, memos, PowerPoints, policy briefs and reports submitted to the ISED Minister from June 1, 2019 to November 19, 2020.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
December 2020

Req # A-2020-18442

A detailed summary of all occasions the PMPRB has used the excessive price penalty for pharmaceutical companies, broken down by date, company penalized, the name of the drug in question, the amount penalized, and a summary of why the price was excessive. Additionally, provide details of how much was collected under the penalty for the past five years and how the money gained from the penalties was used.

Organization: Patented Medicine Prices Review Board Canada

2 page(s)
December 2020

Req # A-2020-18732

A detailed summary of the PMPRB's use of the excessive price penalty on pharmaceutical companies from June 1, 2019 to November 26, 2020. For each penalty, break it down by date, company charged, drug in question, and fine levied.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
December 2020

Nothing to report this month

Organization: Patented Medicine Prices Review Board Canada

November 2020

Nothing to report this month

Organization: Patented Medicine Prices Review Board Canada

October 2020

Req # A-2020-00004

List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.

Organization: Patented Medicine Prices Review Board Canada

4 page(s)
September 2020

Req # A-2020-04135

Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

79 page(s)
September 2020
Date modified: